UH Seidman Cancer Center | Aug. 16, 2025
Empowering Patients with Knowledge and Support
Saturday, August 16, 2025 |Time: 8:30 AM ET | 7:30 AM CT | 6:30 AM MT | 5:30 AM PT
About the Symposium
Join us for a free educational symposium designed to empower melanoma patients, caregivers, and healthcare professionals. Attend in person or online from anywhere in the country. Registration is required for both options.
This Living with Melanoma Symposium brings together leading experts from the University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine to share the latest advances in melanoma treatment, clinical trials, and patient support resources. Whether you are newly diagnosed, undergoing treatment, or a survivor, this symposium offers practical knowledge, inspiration, and community support to help you navigate your melanoma journey with confidence.
What You’ll Learn
- Advances in immunotherapy and how first- and second-line treatments are determined
- Treatment options for inoperable melanoma tumors
- Importance of dermatologic surveillance in melanoma care
- When surgical resection and immunotherapy are indicated
- Clinical trials: understanding the why, when, and which
- Patient resources and support through AIM at Melanoma
- Insights from a patient panel sharing real-life experiences
Event Location (In-Person Attendees)
Midtown Collaboration Center
1974 East 66th Street
Cleveland, Ohio 44103
Parking & Entry:
Free parking is located on East 65th Street between Euclid and Chester Avenues. The MCC is conveniently located on the RTA HealthLine route, making it easily accessible via public transportation.
Register Now
This is a free event, but registration is required for both in-person and virtual attendance. See below to register.
Individual Presentations
8:00 am – 8:30 am
Registration and Breakfast (for in-person attendees)
8:30 am – 8:35 am
Opening and Welcome
Dr. Ankit Mangla, MD
Co-Director Sarcoma and Melanoma Disease Team
University Hospitals Seidman Cancer Center
Associate Professor of Medicine
Division of Hematology and Oncology
Case Western Reserve University School of Medicine
8:35 am – 8: 55 am
Immunotherapy: What Is It and How Do We Determine First Line vs Second Line Treatments?
Dr. Gary Schwartz, MD
Director, Case Comprehensive Cancer Center
Vice Dean for Oncology, School of Medicine
Gertrude Donnelly Hess MD Professor in Oncology Research
8:55 am – 9:15 am
Treatment Options for Inoperable Melanoma Tumors
Iris Y. Sheng, MD
Attending Physician (Division of Cutaneous and GU Oncology)
University Hospitals Seidman Cancer Center
Assistant Professor of Medicine
Division of Hematology and Oncology
Case Western Reserve University School of Medicine
9:15 am – 9: 35 am
Dermatologic Surveillance in Melanoma
Mara Beveridge, MD
Senior Attending Physician (Division of Dermatology)
University Hospitals Seidman Cancer Center
Assistant Professor of Medicine
Division of Dermatology
Case Western Reserve University School of Medicine
9:35 am – 9:50 am
Q & A Session
9:50 am– 10:00 am
Break
10:00 am – 10:20 am
Surgically Resectable Melanoma: When is Immunotherapy Indicated?
Luke Rothermel, MD, MPH
Co-Director Sarcoma and Melanoma Disease Team
Chief, Section of Soft Tissue and GI Surgery
University Hospitals Cleveland Medical Center
Associate Professor of Surgery
Division of Surgical Oncology
Case Western Reserve University School of Medicine
10:20 am – 10:50 am
Clinical Trials: The Why, When and Which of Clinical Trials
Ankit Mangla, MD
Co-Director Sarcoma and Melanoma Disease Team
University Hospitals Seidman Cancer Center
Associate Professor of Medicine
Division of Hematology and Oncology
Case Western Reserve University School of Medicine
10:50 am – 11:05 am
Patient Resources
Ann Garst Taylor
Director Community Engagement
AIM at Melanoma
11:05 am – 11:35 am
The Patient Experience
Patient Panel
11:35 am – 12:00 pm
Q & A Session